|
Control of prostate tumour growth by the long non-coding RNA GHSROS |
35.32 |
|
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA |
25.12 |
|
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells |
12.15 |
|
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay |
10.5 |
|
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells |
9.06 |
|
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP |
8.77 |
|
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells |
8.75 |
|
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO |
8.52 |
|
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex |
8.52 |
|
Oncogenic roles of ARID5B in T-ALL |
8.52 |
|
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A |
7.86 |
|
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) |
7.75 |
|
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes |
7.67 |
|
Transcriptomic analyssis following EHMT1/2 inhibition |
7.09 |
|
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription |
6.82 |
|
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq |
6.82 |
|
Genome wide expression change by RNF168 knocking down in NEC cells |
6.8 |
|
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal |
6.8 |
|
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha |
6.79 |
|
ETV7 and interferon response |
6.79 |
|
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes |
6.79 |
|
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection |
6.78 |
|
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. |
6.72 |
|
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer |
6.69 |
|
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] |
6.69 |
|
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response |
6.64 |
|
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription |
6.49 |
|
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 |
6.45 |
|
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) |
6.41 |
|
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells |
6.37 |
|
Global analysis of enhancer targets: Mosaic-seq |
6.28 |
|
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] |
6.25 |
|
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements |
6.25 |
|
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells |
6.25 |
|
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) |
6.21 |
|
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells |
6.11 |
|
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response |
6.01 |
|
Characterization of parental and rociletinib-resistant derived H1975 cell lines |
5.96 |
|
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] |
5.92 |
|
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts |
5.89 |
|
MYCi975 regulates MYC target genes |
5.8 |
|
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing |
5.75 |
|
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer |
5.69 |
|
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade |
5.6 |
|
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods |
5.5 |
|
The cohesin complex prevents Myc-induced replication stress |
5.4 |
|
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) |
5.37 |
|
Comprehensive comparative analysis of 5’ end RNA sequencing methods |
5.3 |
|
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) |
5.03 |
|
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] |
4.86 |
|
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells |
4.84 |
|
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors |
4.74 |
|
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors |
4.74 |
|
Human Treg IL-12 stimulation |
4.69 |
|
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution |
4.68 |
|
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] |
4.68 |
|
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer |
4.63 |
|
DART-seq: an antibody-free method for global m6A detection |
4.62 |
|
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 |
4.61 |
|
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) |
4.56 |
|
A transcriptome-wide divergence in protein translation scales with LIN28B expression |
4.51 |
|
scRNASeq analysis of cycling cardiomyocytes |
4.5 |
|
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 |
4.49 |
|
A549 cells and MSR-A549 cells |
4.47 |
|
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment |
4.47 |
|
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines |
4.43 |
|
Impact of dieldrin on transcription in Jurkat T cells |
4.42 |
|
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown |
4.42 |
|
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer |
4.38 |
|
Wnt addiction of genetically defined cancers reversed by PORCN inhibition |
4.35 |
|
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. |
4.31 |
|
The regulation of ferroptosis by TAZ in epithelial ovarian cancer |
4.24 |
|
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells |
4.21 |
|
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase |
4.18 |
|
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation |
4.18 |
|
CD73 knockdown effect in pancreatic cancer cell lines |
4.15 |
|
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation |
4.11 |
|
Differential gene expression of human melanoma cells [RNA-seq] |
4.11 |
|
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 |
4.11 |
|
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) |
4.07 |
|
Lysine benzoylation is a novel histone mark |
4.07 |
|
Lysine benzoylation is a novel histone mark [RNA-seq] |
4.07 |
|
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) |
4.04 |
|
Tumor hypoxia causes DNA hypermethylation by reducing TET activity |
4.04 |
|
Nuclear Parkin Regulates Transcriptional Response during Hypoxia |
4.03 |
|
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells |
4.03 |
|
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation |
4.0 |
|
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes |
3.99 |
|
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase |
3.99 |
|
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication |
3.99 |
|
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells |
3.96 |
|
UMI-count modeling and differential expression analysis for single-cell RNA sequencing |
3.94 |
|
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) |
3.91 |
|
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection |
3.91 |
|
Regulation of protein translation during mitosis |
3.86 |
|
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator |
3.82 |
|
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] |
3.82 |
|
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment |
3.81 |
|
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells |
3.77 |
|
Generating Patterned Kidney Organoids for Studying Development and Diseases |
3.74 |
|
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] |
3.73 |
|
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation |
3.73 |
|
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer |
3.73 |
|
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA |
3.72 |
|
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation |
3.66 |
|
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) |
3.65 |
|
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA |
3.62 |
|
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells |
3.61 |
|
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] |
3.58 |
|
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer |
3.58 |
|
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells |
3.57 |
|
N6-methyladenine DNA Modification in Glioblastoma |
3.57 |
|
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] |
3.57 |
|
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. |
3.53 |
|
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes |
3.52 |
|
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID |
3.48 |
|
RNAseq of HEK293 cells after Chtop knockdown |
3.47 |
|
Co-transcriptional loading of RNA export factors shapes the human transcriptome |
3.47 |
|
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] |
3.46 |
|
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells |
3.46 |
|
IGF2BP3 controls cancer cell invasiveness by modulation RISC function |
3.44 |
|
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer |
3.4 |
|
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E |
3.39 |
|
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype |
3.35 |
|
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] |
3.35 |
|
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC |
3.34 |
|
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes |
3.31 |
|
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] |
3.31 |
|
Identification of HOXB13 target genes responsive to BET inhibitors |
3.29 |
|
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 |
3.27 |
|
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] |
3.27 |
|
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells |
3.26 |
|
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium |
3.25 |
|
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression |
3.22 |
|
The landscape of alternative splicing in aggressive prostate cancers |
3.2 |
|
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression |
3.2 |
|
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] |
3.2 |
|
The comparison of high-throughput single-cell RNA-seq methods |
3.19 |
|
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome |
3.19 |
|
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor |
3.17 |
|
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] |
3.17 |
|
Oncogenic MYC induces a dependency on the spliceosome in human cancer |
3.15 |
|
m6A-dependent regulation of messenger RNA stability |
3.14 |
|
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. |
3.13 |
|
CROP-Seq in Primary Human T Cells |
3.11 |
|
Effect of Influenza virus infection on lncRNA expression in A549 cells |
3.1 |
|
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells |
3.09 |
|
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer |
3.09 |
|
TGF-β promotes genomic instability after loss of RUNX3 |
3.08 |
|
RNA-seq analysis of control and Myc-induced U2OS cells |
3.08 |
|
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines |
3.06 |
|
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] |
3.06 |
|
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers |
3.04 |
|
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer |
3.03 |
|
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] |
3.03 |
|
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression |
3.02 |
|
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] |
3.01 |
|
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability |
3.01 |
|
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) |
3.01 |
|
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics |
3.0 |
|
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture |
2.98 |
|
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos |
2.97 |
|
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment |
2.93 |
|
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression |
2.92 |
|
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs |
2.92 |
|
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] |
2.92 |
|
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion |
2.91 |
|
Hypoxic transcriptome of SQ20B human head and neck cancer cells |
2.9 |
|
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression |
2.88 |
|
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. |
2.88 |
|
Trans-differentiation of human adult peripheral blood T cells into neurons |
2.87 |
|
SF3B1 Degron knockdown RNA-seq |
2.86 |
|
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential |
2.85 |
|
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) |
2.83 |
|
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] |
2.82 |
|
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] |
2.81 |
|
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing |
2.8 |
|
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] |
2.8 |
|
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function |
2.8 |
|
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) |
2.79 |
|
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease |
2.79 |
|
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells |
2.77 |
|
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells |
2.77 |
|
Silencing p300 in MCF7 cells to study expression and alternative splicing |
2.76 |
|
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth |
2.76 |
|
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains |
2.75 |
|
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development |
2.75 |
|
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment |
2.74 |
|
RNA-seq analyisis of PUM2 knockout cells |
2.74 |
|
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions |
2.73 |
|
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines |
2.72 |
|
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes |
2.72 |
|
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 |
2.72 |
|
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 |
2.72 |
|
Effect of from Human Umbilical Vein Endothelial Cells |
2.71 |
|
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization |
2.7 |
|
Retinoic acid suppresses MYB in adenoid cystic carcinoma |
2.7 |
|
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] |
2.7 |
|
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression |
2.7 |
|
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types |
2.7 |
|
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns |
2.7 |
|
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes |
2.69 |
|
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters |
2.68 |
|
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs |
2.65 |
|
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels |
2.65 |
|
Tracing Enhancer Networks using Epigenetic Traits (TENET) |
2.64 |
|
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] |
2.63 |
|
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 |
2.63 |
|
RNA-seq analyses of human prostate cancer cells |
2.63 |
|
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends |
2.62 |
|
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage |
2.61 |
|
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs |
2.6 |
|
Cell responses to dysregulated VZV-induced cell-cell fusion |
2.59 |
|
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells |
2.56 |
|
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant |
2.55 |
|
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant |
2.55 |
|
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells |
2.55 |
|
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells |
2.53 |
|
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance |
2.53 |
|
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO |
2.53 |
|
Transcription elongation factors are in vivo-specific cancer dependencies in glioma |
2.52 |
|
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma |
2.52 |
|
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] |
2.51 |
|
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability |
2.51 |
|
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression |
2.51 |
|
CRISPR adenine and cytosine base editors with reduced RNA off-target activities |
2.5 |
|
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] |
2.5 |
|
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma |
2.49 |
|
T47D RNA-seq and ChrRNA-seq data |
2.49 |
|
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription |
2.49 |
|
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells |
2.48 |
|
Ribosome profiling upon inhibition of eIF4A |
2.47 |
|
Illumina Total RNA-seq in HeLa |
2.45 |
|
Identification of transcription start sites for human A549 cell line using ReCappable-seq |
2.45 |
|
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs |
2.44 |
|
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer |
2.4 |
|
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation |
2.38 |
|
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases |
2.36 |
|
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations |
2.35 |
|
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration |
2.3 |
|
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] |
2.29 |
|
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] |
2.29 |
|
Regulatory network controlling tumor-promoting inflammation in human cancers |
2.29 |
|
Functional significance of the HIV-1 Tat signature amino acid residues |
2.26 |
|
MCF-7 as a model for functional analysis of breast cancer risk variants |
2.26 |
|
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation |
2.26 |
|
KLF6-dependent transcription in renal cancer cells |
2.22 |
|
FBXW7 modulates stress response by post-translational modification of HSF1 |
2.21 |
|
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. |
2.21 |
|
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors |
2.18 |
|
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) |
2.14 |
|
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells |
2.12 |
|
Hijacking of stress response machinery by oncogenes in acute leukaemia |
2.11 |
|
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] |
2.11 |
|
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer |
2.1 |
|
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification |
2.09 |
|
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy |
2.06 |
|
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] |
2.05 |
|
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures |
2.05 |
|
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance |
2.04 |
|
Transcriptome analysis of SKI knock-out in HL60 cells |
2.03 |
|
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 |
2.03 |
|
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks |
2.0 |
|
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells |
1.98 |
|
Paxillin regulates genomic networks in prostate cancer [C4-2] |
1.98 |
|
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance |
1.97 |
|
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') |
1.97 |
|
A single cell reference map for human blood and tissue T cell activation |
1.96 |
|
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] |
1.95 |
|
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells |
1.92 |
|
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] |
1.92 |
|
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. |
1.9 |
|
Mediator kinase inhibition further activates super-enhancer-associated genes in AML |
1.9 |
|
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] |
1.9 |
|
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock |
1.9 |
|
RNA-seq of IL-4 stimulated human keratinocytes |
1.89 |
|
Functional role of SLIT2 and ROBO1 in trophoblasts |
1.89 |
|
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct |
1.89 |
|
Seletive inhibition of CDK9 in DLBCL cell lines |
1.86 |
|
Overexpression and knockdown experiment for circCSNK1G3 |
1.85 |
|
Human Treg NaCl stimulation |
1.85 |
|
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells |
1.85 |
|
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma |
1.84 |
|
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin |
1.8 |
|
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] |
1.79 |
|
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition |
1.78 |
|
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] |
1.78 |
|
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression |
1.78 |
|
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons |
1.78 |
|
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases |
1.76 |
|
Characterisation of the myeloid differentiation process of human hematopoietic stem cells |
1.76 |
|
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer |
1.76 |
|
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) |
1.76 |
|
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] |
1.74 |
|
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer |
1.74 |
|
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer |
1.72 |
|
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer |
1.72 |
|
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins |
1.71 |
|
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] |
1.71 |
|
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma |
1.71 |
|
Low carbohydrate diet study for non-alcoholic fatty liver disease patients |
1.71 |
|
Transcriptome landscape of HeLa response upon triamcinolone acetonide |
1.71 |
|
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] |
1.69 |
|
Genome wide miR-191 target profile determined by RIP and gene expression profiling |
1.69 |
|
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 |
1.69 |
|
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) |
1.69 |
|
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes |
1.69 |
|
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I |
1.68 |
|
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. |
1.68 |
|
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene |
1.67 |
|
Iron response of HepG2 cells |
1.65 |
|
RNA-sequencing of the GSI treatment of the CUTLL1 cell line |
1.65 |
|
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 |
1.65 |
|
Cajal bodies are linked to genome conformation [RNA-Seq] |
1.64 |
|
Cajal bodies are linked to genome conformation |
1.64 |
|
Effect of CHKA knockdown on C4-2 cell transcriptome |
1.64 |
|
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome |
1.64 |
|
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome |
1.63 |
|
mRNA recovered upon RNF219 IP. [RNA-IP] |
1.62 |
|
Transcriptional profile in human S. haematobium infection |
1.6 |
|
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] |
1.58 |
|
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders |
1.58 |
|
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors |
1.57 |
|
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway |
1.55 |
|
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel |
1.54 |
|
ENCODE Cold Spring Harbor Labs Long RNA-seq |
1.53 |
|
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer |
1.53 |
|
Genes altered in expression by Cisplatin treatment in lung cancer cell lines |
1.51 |
|
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles |
1.51 |
|
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers |
1.5 |
|
RNA-seq analysis upon ARID1B overexpression |
1.49 |
|
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma |
1.48 |
|
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] |
1.48 |
|
PRDM1 inhibits proliferation of human colon cancer organoids |
1.46 |
|
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] |
1.45 |
|
RNA editing in nascent RNA affects pre-mRNA splicing |
1.45 |
|
Transcriptome sequencing of K-562 cells |
1.44 |
|
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome |
1.43 |
|
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential |
1.42 |
|
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing |
1.42 |
|
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells |
1.41 |
|
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) |
1.4 |
|
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia |
1.4 |
|
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] |
1.39 |
|
NR2F2 study |
1.39 |
|
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors |
1.37 |
|
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment |
1.34 |
|
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming |
1.32 |
|
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas |
1.32 |
|
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis |
1.31 |
|
Chromatin landscape of human visceral and subcutaneous adipocytes |
1.3 |
|
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner |
1.3 |
|
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) |
1.29 |
|
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] |
1.29 |
|
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes |
1.29 |
|
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. |
1.28 |
|
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) |
1.23 |
|
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) |
1.23 |
|
An integrative analysis of non-coding regulatory DNA variations associated with autism |
1.22 |
|
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells |
1.19 |
|
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 |
1.18 |
|
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers |
1.17 |
|
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD |
1.17 |
|
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells |
1.15 |
|
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape |
1.11 |
|
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells |
1.04 |
|
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation |
1.03 |
|
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] |
1.03 |
|
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination |
1.03 |
|
SNHG5 siRNA knock down in HCT116 cells |
1.02 |
|
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer |
1.01 |
|
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness |
1.0 |
|
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells |
0.99 |
|
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] |
0.98 |
|
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures |
0.98 |
|
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] |
0.98 |
|
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines |
0.96 |
|
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma |
0.95 |
|
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment |
0.95 |
|
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells |
0.94 |
|
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] |
0.94 |
|
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant |
0.93 |
|
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells |
0.93 |
|
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s |
0.93 |
|
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit |
0.9 |
|
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown |
0.89 |
|
Cell cycle dynamics of human pluripotent stem cells primed for differentiation |
0.89 |
|
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin |
0.89 |
|
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line |
0.87 |
|
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line |
0.87 |
|
Transcriptomic analysis of human tonsillar TFH subsets |
0.87 |
|
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells |
0.87 |
|
Effect of ILF3 on translation during homeostasis and the antiviral response |
0.84 |
|
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown |
0.82 |
|
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] |
0.82 |
|
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs |
0.81 |
|
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) |
0.79 |
|
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells |
0.77 |
|
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression |
0.75 |
|
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] |
0.75 |
|
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas |
0.73 |
|
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments |
0.72 |
|
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution |
0.71 |
|
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors |
0.71 |
|
Unraveling cis-regulatory elements by mapping structural changes in mRNAs |
0.7 |
|
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs |
0.69 |
|
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response |
0.68 |
|
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells |
0.68 |
|
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer |
0.68 |
|
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF |
0.66 |
|
Effect of PBK knockdown on C4-2 cell transcriptome |
0.66 |
|
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] |
0.65 |
|
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo |
0.65 |
|
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation |
0.63 |
|
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? |
0.62 |
|
Impact on erythroid progenitor type on erythroid differntiation |
0.61 |
|
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells |
0.6 |
|
RNAseq of cell lines with knocked in ESR1 mutations |
0.59 |
|
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] |
0.57 |
|
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 |
0.57 |
|
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation |
0.57 |
|
Gene Expression Profiling of WT and KDM3A Knocked out Cell |
0.57 |
|
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells |
0.57 |
|
TT-Seq captures the human transient transcriptome |
0.57 |
|
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts |
0.56 |
|
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells |
0.56 |
|
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. |
0.56 |
|
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) |
0.54 |
|
Epigenetic reprogramming of melanoma cells by vitamin C treatment |
0.54 |
|
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing |
0.54 |
|
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates |
0.53 |
|
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) |
0.53 |
|
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet |
0.52 |
|
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment |
0.52 |
|
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. |
0.52 |
|
Human cells contain natural double-stranded RNAs with potential regulatory capacity |
0.51 |
|
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] |
0.5 |
|
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis |
0.5 |
|
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) |
0.49 |
|
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm |
0.49 |
|
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 |
0.48 |
|
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa |
0.47 |
|
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula |
0.47 |
|
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies |
0.47 |
|
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) |
0.45 |
|
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] |
0.45 |
|
ARS2 is a general suppressor of pervasive transcription [RNAseq] |
0.45 |
|
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 |
0.45 |
|
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells |
0.44 |
|
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export |
0.42 |
|
Transcriptome-wide response to synthetic chromatin protein PcTF |
0.42 |
|
Gene expression changes due to PARP knockdown in human cells |
0.42 |
|
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer |
0.42 |
|
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA |
0.42 |
|
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq |
0.4 |
|
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients |
0.4 |
|
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture |
0.39 |
|
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation |
0.39 |
|
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis |
0.39 |
|
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) |
0.37 |
|
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells |
0.37 |
|
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome |
0.36 |
|
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression |
0.35 |
|
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing |
0.32 |
|
Cystathionine-β-Synthase Promotes Colon Carcinogenesis |
0.3 |
|
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression |
0.28 |
|
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures |
0.27 |
|
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis |
0.26 |
|
HEK293 TFAM Knockout Expression Study |
0.26 |
|
Human Treg IFNg/IL-10 subpopulations |
0.24 |
|
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol |
0.24 |
|
Disease modelling of core pre-mRNA splicing factor haploinsufficiency |
0.23 |
|
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) |
0.21 |
|
RNA seq with AML (NB4) cells upon FTO inhibition |
0.21 |
|
RNA seq analysis of human Fetal and adult derived Enterospheres |
0.2 |
|
Exploring ILF2 regulatory genes by next-generation sequencing |
0.2 |
|
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence |
0.19 |
|
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] |
0.19 |
|
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer |
0.19 |
|
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment |
0.18 |
|
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation |
0.16 |
|
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 |
0.16 |
|
Generation and persistence of human tissue-resident memory T cells in lung transplantation |
0.15 |
|
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. |
0.13 |
|
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition |
0.11 |
|
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity |
0.11 |
|
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes |
0.11 |
|
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 |
0.1 |
|
RNA-seq data |
0.08 |
|
Genome-wide analysis of the Integrator complex |
0.08 |
|
Genome-wide analysis of the Integrator complex (HTS) |
0.08 |
|
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. |
0.06 |
|
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells |
0.05 |
|
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells |
0.05 |
|
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness |
0.04 |
|
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. |
0.04 |
|
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells |
0.02 |
|
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] |
0.0 |
|
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates |
0.0 |
|
O-glcnAc reprograms cellular energetics |
0.0 |